Literature DB >> 15477299

Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results.

W J Lesterhuis1, I J M de Vries, G J Adema, C J A Punt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15477299     DOI： 10.1093/annonc/mdh919

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  16 in total

Review 1.  Translating tumor antigens into cancer vaccines.

Authors:  Luigi Buonaguro; Annacarmen Petrizzo; Maria Lina Tornesello; Franco M Buonaguro
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

2.  RAFTsomes containing epitope-MHC-II complexes mediated CD4+ T cell activation and antigen-specific immune responses.

Authors:  Qian Ding; Jian Chen; Xiaohui Wei; Wenqiang Sun; Junhua Mai; Yanzhu Yang; Yuhong Xu
Journal:  Pharm Res       Date:  2012-08-10       Impact factor: 4.200

Review 3.  Tissue-resident dendritic cells and diseases involving dendritic cell malfunction.

Authors:  Keqiang Chen; Ji Ming Wang; Ruoxi Yuan; Xiang Yi; Liangzhu Li; Wanghua Gong; Tianshu Yang; Liwu Li; Shaobo Su
Journal:  Int Immunopharmacol       Date:  2016-02-22       Impact factor: 4.932

Review 4.  Vaccines against myasthenia gravis.

Authors:  Sonia Berrih-Aknin; Sara Fuchs; Miriam C Souroujon
Journal:  Expert Opin Biol Ther       Date:  2005-07       Impact factor: 4.388

5.  Improved efficacy of dendritic cell-based immunotherapy by cutaneous laser illumination.

Authors:  Xinyuan Chen; Qiyan Zeng; Mei X Wu
Journal:  Clin Cancer Res       Date:  2012-03-05       Impact factor: 12.531

Review 6.  DC-based cancer vaccines.

Authors:  Eli Gilboa
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 7.  Strategies for cancer vaccine development.

Authors:  Matteo Vergati; Chiara Intrivici; Ngar-Yee Huen; Jeffrey Schlom; Kwong Y Tsang
Journal:  J Biomed Biotechnol       Date:  2010-07-11

Review 8.  Dendritic cell tumor killing activity and its potential applications in cancer immunotherapy.

Authors:  Neale Hanke; Darya Alizadeh; Emmanuel Katsanis; Nicolas Larmonier
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

Review 9.  Strategies for enhancing vaccine-induced CTL antitumor immune responses.

Authors:  Xin Yong; Yü-Feng Xiao; Gang Luo; Bin He; Mu-Han Lü; Chang-Jiang Hu; Hong Guo; Shi-Ming Yang
Journal:  J Biomed Biotechnol       Date:  2012-10-02

10.  Cancer vaccine development: designing tumor cells for greater immunogenicity.

Authors:  Erica N Bozeman; Rangaiah Shashidharamurthy; Simon A Paulos; Ravi Palaniappan; Martin D'Souza; Periasamy Selvaraj
Journal:  Front Biosci (Landmark Ed)       Date:  2010-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.